Trailblazers in Glaucoma Research by Harnessing Innovative and Effective Clinical Trial Management

#Glaucomaawarenessmonth. This Glaucoma awareness month, we focus on the support provided by Navitas Life Sciences in managing efficient clinical trials. Navitas Life Sciences has been transforming the management of clinical trials using effective operation strategies, applying technology to increase the speed of decision making and utilizing the vast experience of our experts.

Global Strategic Partners for Efficient Clinical Trials

Our 30 years of experience in conducting clinical trials is leveraged to make clinical trials cost and time efficient. Our ability to understand challenges and provide unique solutions have emerged as a critical tool in this pursuit. We support the management of clinical trials from phase I to phase IV, backed by technology & analytics to meet the critical challenges.

IDMP

Glaucoma Clinical Trials

4.5 million people globally are blind due to glaucoma, according to the World Health Organization. It has been estimated that nearly 12 million Indians and about 3 million Americans have glaucoma and primary angle glaucoma, respectively. Glaucoma is also known to be the leading cause of blindness in people over 60 years.

Considering the large numbers of people with glaucoma and the gap that exists in care, it is imperative to find improved solutions for people who most need them. Navitas Life Sciences supports the drive for improved care for people with glaucoma by managing glaucoma clinical trials.

Our resilient and rapidly evolving strategies capture the essence of clinical trial requirements, with delivery at substantial speed and quality. As a result, we are strategic partners for multiple small, mid to large pharma companies.

Equipment Available for Glaucoma Clinical Trials

  • Ultrasound Pachymetry
  • Humphrey Field Analyzer
  • Biomicroscopy
  • Gonioscopy
  • Ophthalmoscope
  • IOP (Goldman Applanation Tonometry)

Patient centric care

Our patient centric trials ensure that patients get the right support throughout the study. Their vision is checked by trained experts with physical assistance to better manage their condition.

Our investment in digital technology has enabled the use of digital tools for improved patient engagement, and off site care.

Benefits of Choosing Navitas Life Sciences for Glaucoma Clinical Trials

  • Specialists with vast experience
  • Technology led Clinical Trials
  • Multiple Ophthalmology sites
  • Global experience in conducting glaucoma clinical trials

Use of AI for Faster Decision Making

OneClinical® Analytics is an AI based data analysis platform that provides near real time data during a clinical trial for smarter decisions regarding the progress of the trial. The use of such intelligent analytics aids in taking proactive corrective action, resolving critical issues at the onset. This will help in intelligent deployment of resources which can save time and cost.

IDMP

Intelligent and Unified Data Analytics and Aggregation for 5 Clinical Trials, from 3 CROs, and 3 EDC Platforms using OneClinical® Analytics

Our client a global clinical-stage biopharmaceutical company headquartered in New Jersey, USA, was seeking a partner to help aggregate clinical trial data from 5 different clinical studies, being managed by 3 different Clinical Research Organizations (CROs) and using 3 different Electronic Data Capture (EDC) systems.

Read our case study to learn how we worked with our client to unify data analytics and aggregation across 5 clinical trials, 3 CROs, and 3 varied EDC platforms utilizing OneClinical® Analytics to power intelligent study oversight and medical monitoring

Are you looking for support for your glaucoma clinical trials? Speak to our experts to know more about our services and solutions by reaching out to us at This email address is being protected from spambots. You need JavaScript enabled to view it..

Meet the Speakers for the Webinar on Technology En...
Top Highlights from 2022 - Five Exciting Studies Y...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us